However, in poststroke patients, CSF t-tau increases in association with stroke severity, while p-tau does not.7 This strengthens the view that p-tau is a marker for AD-type tau pathology, while t-tau reflects neuronal injury, a notion later supported by associations between p-tau and tau positron emission tomography signal.8 The gene discussed is MAPT; the disease is Alzheimer disease.